The FDA has granted marketing approval of the first ZnT8Ab test to help determine if a person has type 1 diabetes.
A non-invasive prenatal screening assay that can assess for multiple fetal chromosomal aneuploidies has been approved
Exact Sciences has announced the FDA approval of Cologuard, the first non-invasive DNA screening test for colorectal cancer.
Nonadherent MRI utilization is tied to a cascade of higher medical costs and potentially unnecessary and unhelpful medical services following the MRI.
For children with pelvic fractures or dislocations after blunt trauma, plain anteroposterior pelvic radiographs have limited sensitivity.
The FDA has issued a final guidance on the development, review, and approval or clearance of companion diagnostics.
Millions of American women have benefited from a breast and cervical cancer screening program offered by the CDC.
Review this chart for quick information when you need it.